Oncogenic transcription factors as master regulators of chromatin topology: A new role for ERG in prostate cancer

Cell Cycle

Volumn 11, Issue 18, 2012, Pages 3380-3383

  Elemento, Olivier ^a   Rubin, Mark A ^a   Rickman, David S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Chromatin topology; ERG; Oncogenic transcription factor; Prostate cancer; Translocation

Indexed keywords

TRANSCRIPTION FACTOR ERG;

CHROMATIN; CHROMATIN TOPOLOGY; CHROMOSOME MAP; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; CONTROLLED STUDY; GENE FUSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; INTERCHROMOSOME INTERACTION; INTRACHROMOSOME INTERACTION; PROSTATE CANCER; REGULATORY MECHANISM; REPRODUCIBILITY; REVIEW;

EID: 84866754239     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21401     Document Type: Review

References (27)

1. Osborne CS, Chakalova L, Brown KE, Carter D, Horton A, Debrand E, et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 2004; 36:1065-71; PMID:15361872; http://dx.doi.org/10.1038/ng1423.
2. Sexton T, Schober H, Fraser P, Gasser SM. Gene regulation through nuclear organization. Nat Struct Mol Biol 2007; 14:1049-55; PMID:17984967; http://dx.doi.org/10.1038/nsmb1324.
3. Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009; 326:289-93; PMID:19815776; http://dx.doi.org/10.1126/science.1181369.
4. Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012; 485:376-80; PMID:22495300; http://dx.doi.org/10.1038/nature11082.
5. Zhang Y, McCord RP, Ho YJ, Lajoie BR, Hildebrand DG, Simon AC, et al. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 2012; 148:908-21; PMID:22341456; http://dx.doi.org/10.1016/ j.cell.2012.02.002.
6. Sexton T, Yaffe E, Kenigsberg E, Bantignies F, Leblanc B, Hoichman M, et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell 2012; 148:458-72; PMID:22265598; http://dx.doi.org/10. 1016/j.cell.2012.01.010.
7. Duan Z, Andronescu M, Schutz K, McIlwain S, Kim YJ, Lee C, et al. A three-dimensional model of the yeast genome. Nature 2010; 465:363-7; PMID:20436457; http://dx.doi.org/10.1038/nature08973.
8. De S, Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol 2011; 29:1103-8; PMID:22101487; http://dx.doi.org/10.1038/nbt.2030.
9. Fudenberg G, Getz G, Meyerson M, Mirny LA. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat Biotechnol 2011; 29:1109-13; PMID:22101486; http://dx.doi.org/10.1038/nbt.2049.
10. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C, et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008; 21:1156-67; PMID:18567993; http://dx.doi.org/ 10.1038/modpathol.2008.111.
11. Koh CM, Bieberich CJ, Dang CV, Nelson WG, Yegnasubramanian S, De Marzo AM. MYC and Prostate Cancer. Genes Cancer 2010; 1:617-28; PMID:21779461; http://dx.doi.org/10.1177/1947601910379132.
12. Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007; 31:882-8; PMID:17527075; http://dx.doi.org/10. 1097/01.pas.0000213424.38503.aa.
13. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331:294-9; PMID:8022439; http://dx.doi.org/10.1056/NEJM199408043310503.
14. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 1982; 79:7824-7; PMID:6961453; http://dx.doi.org/10.1073/pnas.79.24.7824.
15. Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, et al. A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci U S A 2008; 105:2105-10; PMID:18245377; http://dx.doi.org/10.1073/ pnas.0711711105.
16. Rickman DS, Chen YB, Banerjee S, Pan Y, Yu J, Vuong T, et al. ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. Neoplasia 2010; 12:1031-40; PMID:21170267.
17. Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 2008; 10:177-88; PMID:18283340; http://dx.doi.org/10.1593/neo.07822.
18. Koh CM, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S, De Marzo AM. Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. Oncotarget 2011; 2:669-83; PMID:21941025.
19. Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 2010; 17:443-54; PMID:20478527; http://dx.doi.org/10.1016/j.ccr.2010.03.018.
20. Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S, et al. Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A 2012; 109:9083-8; PMID:22615383; http://dx.doi.org/10.1073/pnas.1112570109.
21. Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 2011; 19:664-78; PMID:21575865; http://dx.doi.org/10.1016/j.ccr.2011.04.010.
22. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al. The genomic complexity of primary human prostate cancer. Nature 2011; 470:214-20; PMID:21307934; http://dx.doi.org/10.1038/nature09744.
23. Rausch T, Jones DT, Zapatka M, Stütz AM, Zichner T, Weischenfeldt J, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012; 148:59-71; PMID:22265402; http://dx.doi.org/10.1016/j.cell.2011.12.013.
24. Marti-Renom MA, Mirny LA. Bridging the resolution gap in structural modeling of 3D genome organization. PLoS Comput Biol 2011; 7:e1002125; PMID:21779160; http://dx.doi.org/10.1371/journal.pcbi.1002125.
25. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144:27-40; PMID:21215367; http://dx.doi.org/10. 1016/j.cell.2010.11.055.
26. Hollenhorst PC, Shah AA, Hopkins C, Graves BJ. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev 2007; 21:1882-94; PMID:17652178; http://dx.doi.org/10. 1101/gad.1561707.
27. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, et al. Non-transcriptional control of DNA replication by c-Myc. Nature 2007; 448:445-51; PMID:17597761; http://dx.doi.org/10.1038/nature05953.